Neurocrine Bioscienc (NBIX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 74,195 | 31,014 | 44,789 | 63,754 | 50,107 |
| Marketable Securities | 304,996 | 162,795 | 100,950 | 109,259 | 78,996 |
| Receivables | N/A | N/A | N/A | 14,089 | 1,903 |
| Other current assets | 4,883 | 4,394 | 2,723 | 2,162 | 1,470 |
| TOTAL | $384,074 | $198,203 | $148,462 | $189,264 | $132,476 |
| Non-Current Assets | |||||
| PPE Net | 3,432 | 2,507 | 1,771 | 1,900 | 1,586 |
| Investments And Advances | 82,488 | 37,492 | 0 | 480 | 0 |
| Other Non-Current Assets | 4,791 | 4,831 | 4,443 | 4,335 | 4,306 |
| TOTAL | $90,711 | $44,830 | $6,214 | $6,715 | $5,892 |
| Total Assets | $474,785 | $243,033 | $154,676 | $195,979 | $138,368 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 269 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | 2,561 | 246 | 101 | 911 | 1,111 |
| Accrued Expenses | 19,034 | 11,508 | 7,955 | 8,094 | 8,451 |
| TOTAL | $25,715 | $15,664 | $11,699 | $15,646 | $47,110 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 3,423 | 3,443 | 3,227 | 6,052 | 37,284 |
| Other Non-Current Liabilities | 1,932 | 2,137 | 2,242 | 1,992 | 1,925 |
| TOTAL | $24,616 | $18,670 | $22,567 | $25,961 | $31,177 |
| Total Liabilities | $50,331 | $34,334 | $34,266 | $41,607 | $78,287 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 86,453 | 77,163 | 67,794 | 66,509 | 66,240 |
| Common Shares | 86 | 76 | 67 | 66 | 55 |
| Retained earnings | -915,234 | -826,305 | -765,763 | -719,673 | -724,698 |
| Other shareholders' equity | -977 | -277 | 5 | -2 | -87 |
| TOTAL | $424,454 | $208,699 | $120,410 | $154,372 | $60,081 |
| Total Liabilities And Equity | $474,785 | $243,033 | $154,676 | $195,979 | $138,368 |